Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shorena Janelidze

Showing results (1-10 of 247) with videos related to

Pageof 25
Sort By:
Nature Medicine|November 3, 2025
A new blood biomarker for Alzheimer's diseaseShorena Janelidze
Modern Trends in Pharmacopsychiatry|September 17, 2014
Inflammation in suicidality: implications for novel treatment optionsShorena Janelidze, Lena Brundin
Alzheimer'S Research & Therapy|February 8, 2024
Effects of certain pre-analytical factors on the performance of plasma phospho-tau217Divya Bali, Oskar Hansson, Shorena Janelidze
Alzheimer'S Research & Therapy|July 21, 2019
Towards a unified protocol for handling of CSF before β-amyloid measurementsShorena Janelidze, Erik Stomrud, Britta Brix, et al.
The Journal of Gene Medicine|October 11, 2014
Pre-existing immunity to adeno-associated virus (AAV)2 limits transgene expression following intracerebral AAV2-based gene delivery in a 6-hydroxydopamine model of Parkinson's diseaseShorena Janelidze, Ulrika Nordström, Sebastian Kügler, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|May 21, 2016
The Swedish SCOPA-SLEEP for assessment of sleep disorders in Parkinson's disease and healthy controlsPeter Hagell, Albert Westergren, Shorena Janelidze, et al.
Behavioural Brain Research|April 7, 2011
Changes in behaviour and cytokine expression upon a peripheral immune challengeCecilie Bay-Richter, Shorena Janelidze, Ludvig Hallberg, et al.
United European Gastroenterology Journal|March 28, 2020
Clinical outcomes with ustekinumab as rescue treatment in therapy-refractory or therapy-intolerant ulcerative colitisThomas Ochsenkühn, Cornelia Tillack, Daniel Szokodi, et al.
Brain, Behavior, and Immunity|October 19, 2010
Cytokine levels in the blood may distinguish suicide attempters from depressed patientsShorena Janelidze, Daniele Mattei, Åsa Westrin, et al.
Cytokine|September 18, 2012
Aldosterone synergizes with peripheral inflammation to induce brain IL-1β expression and depressive-like effectsCecilie Bay-Richter, Ludvig Hallberg, Filip Ventorp, et al.
Pageof 25

Showing results (1-10 of 247) with videos related to

Sort By:
Pageof 25
Nature Medicine|November 3, 2025
A new blood biomarker for Alzheimer's diseaseShorena Janelidze
Modern Trends in Pharmacopsychiatry|September 17, 2014
Inflammation in suicidality: implications for novel treatment optionsShorena Janelidze, Lena Brundin
Alzheimer'S Research & Therapy|February 8, 2024
Effects of certain pre-analytical factors on the performance of plasma phospho-tau217Divya Bali, Oskar Hansson, Shorena Janelidze
Alzheimer'S Research & Therapy|July 21, 2019
Towards a unified protocol for handling of CSF before β-amyloid measurementsShorena Janelidze, Erik Stomrud, Britta Brix, et al.
The Journal of Gene Medicine|October 11, 2014
Pre-existing immunity to adeno-associated virus (AAV)2 limits transgene expression following intracerebral AAV2-based gene delivery in a 6-hydroxydopamine model of Parkinson's diseaseShorena Janelidze, Ulrika Nordström, Sebastian Kügler, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|May 21, 2016
The Swedish SCOPA-SLEEP for assessment of sleep disorders in Parkinson's disease and healthy controlsPeter Hagell, Albert Westergren, Shorena Janelidze, et al.
Behavioural Brain Research|April 7, 2011
Changes in behaviour and cytokine expression upon a peripheral immune challengeCecilie Bay-Richter, Shorena Janelidze, Ludvig Hallberg, et al.
United European Gastroenterology Journal|March 28, 2020
Clinical outcomes with ustekinumab as rescue treatment in therapy-refractory or therapy-intolerant ulcerative colitisThomas Ochsenkühn, Cornelia Tillack, Daniel Szokodi, et al.
Brain, Behavior, and Immunity|October 19, 2010
Cytokine levels in the blood may distinguish suicide attempters from depressed patientsShorena Janelidze, Daniele Mattei, Åsa Westrin, et al.
Cytokine|September 18, 2012
Aldosterone synergizes with peripheral inflammation to induce brain IL-1β expression and depressive-like effectsCecilie Bay-Richter, Ludvig Hallberg, Filip Ventorp, et al.
Pageof 25